ABERDEEN STD GOLD ETF TR's ticker is SGOL and the CUSIP is 00326A104. A total of 251 filers reported holding ABERDEEN STD GOLD ETF TR in Q2 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $230,554 | -3.7% | 13,033 | 0.0% | 0.12% | +1.7% |
| Q2 2023 | $239,417 | -2.6% | 13,033 | 0.0% | 0.12% | -13.1% |
| Q1 2023 | $245,933 | +8.0% | 13,033 | 0.0% | 0.14% | -2.8% |
| Q4 2022 | $227,687 | +10.0% | 13,033 | 0.0% | 0.14% | +9.3% |
| Q3 2022 | $207,000 | -8.4% | 13,033 | 0.0% | 0.13% | -1.5% |
| Q2 2022 | $226,000 | -12.7% | 13,033 | -6.5% | 0.13% | +5.6% |
| Q1 2022 | $259,000 | +5.7% | 13,939 | 0.0% | 0.12% | +19.2% |
| Q4 2021 | $245,000 | +4.3% | 13,939 | 0.0% | 0.10% | -8.0% |
| Q3 2021 | $235,000 | -0.8% | 13,939 | 0.0% | 0.11% | -2.6% |
| Q2 2021 | $237,000 | +3.5% | 13,939 | -0.4% | 0.12% | -13.4% |
| Q1 2021 | $229,000 | -10.5% | 13,990 | 0.0% | 0.13% | -11.3% |
| Q4 2020 | $256,000 | -29.3% | 13,990 | -29.8% | 0.15% | -34.6% |
| Q3 2020 | $362,000 | -28.5% | 19,930 | -32.6% | 0.23% | -35.1% |
| Q2 2020 | $506,000 | – | 29,550 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prostatis Group LLC | 500,689 | $7,585,438 | 10.78% |
| Almanack Investment Partners, LLC. | 2,310,779 | $35,008,000 | 7.52% |
| Hudock, Inc. | 959,228 | $14,532,000 | 5.71% |
| SimpliFi, Inc. | 595,575 | $9,023,000 | 5.64% |
| UBP Investment Advisors SA | 405,987 | $6,151,000 | 5.56% |
| Allen Capital Group, LLC | 850,481 | $12,885,000 | 3.97% |
| CARY STREET PARTNERS INVESTMENT ADVISORY LLC | 84,266 | $1,276,000 | 2.98% |
| American Money Management, LLC | 302,921 | $4,589,000 | 2.57% |
| WT Wealth Management | 132,453 | $2,006,000 | 2.11% |
| FormulaFolio Investments, LLC | 2,385,654 | $36,143,000 | 1.93% |